
Nanosonics Ltd
ASX:NAN

Operating Margin
Nanosonics Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
AU |
![]() |
Nanosonics Ltd
ASX:NAN
|
1.2B AUD |
7%
|
|
CH |
![]() |
Alcon AG
SIX:ALC
|
36B CHF |
14%
|
|
JP |
![]() |
Hoya Corp
TSE:7741
|
6.4T JPY |
29%
|
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
138.3B DKK |
27%
|
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
14.9B USD |
16%
|
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
5.8B CHF |
15%
|
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
5B GBP |
15%
|
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.6B CNY |
43%
|
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.1B USD |
29%
|
|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
5B USD |
3%
|
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
5B USD |
12%
|
Nanosonics Ltd
Glance View
Nanosonics Ltd. engages in the research, development, and commercialization of infection control and decontamination products and related technologies. The company is headquartered in Sydney, New South Wales and currently employs 339 full-time employees. The company went IPO on 2007-05-17. The firm's principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. The firm is focused on research, development and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generates sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. The firm's products include trophon2, Nanosonics Auditpro, and trophon electron paramagnetic resonance (ERP). trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics Auditpro provides real-time intelligence on ultrasound probes, operators, and infection control events to manage infection prevention practices across organizations.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Nanosonics Ltd's most recent financial statements, the company has Operating Margin of 6.8%.